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Campylobacter spp. has been identified as one of the leading causative agents of food borne 
diarrheal illness.  Epidemiological evidence has shown that poultry is the main source for human 
infection.  Poultry are asymptomatic carriers of Campylobacter within their gastrointestinal tract, 




 cfu/g cecal content.  Surveys of domestic poultry 
flocks have estimated that approximately 90% of flocks are positive for Campylobacter 
colonization.  Risk assessment studies have determined that by reducing levels of Campylobacter 
colonization during rearing, incidences of human infection will be significantly reduced.  
Currently there are no consistently effective treatments to eliminate Campylobacter from poultry 
flocks.  The use of natural plant extracts to control food borne pathogens is an area of resurgent 
interest due to growing consumer demand for removal of sub-theraputic administration of 
antibiotics in conventionally raised livestock and the increased demand for organic meat 
products.  Extracts from American Cranberry (Vaccinium macrocarpon) contain 
proanthocyanidins which have demonstrated antimicrobial activity against other food borne 
pathogens including E. coli, Salmonella, and Listeria.  However, their ability to reduce 
Campylobacter in chickens has not been reported.  The objective of this study was to evaluate 
two different cranberry extracts, either containing a lower (1%) or higher concentration (30%) of 
proanthocyanidins by the manufacturer (L-PAC or H-PAC, respectively), to inhibit the growth of 
Campylobacter, in vitro and in vivo.  In replicate in vitro trials, a 0.1 or 0.5% dose had no effect, 
the 1% dose produced a modest reduction and the 2 or 4% doses produced at least a 5 log 
reduction in Campylobacter counts when compared to controls 8 or 24 hours after inoculation.  
For the in vivo studies, 70 chicks were randomly assigned to one of seven treatment groups 
(n=10 per treatment group).  Treatment groups for each trial included a positive Campylobacter   
 
 
control (no cranberry extract) or 0.5%, 1%, or 2% of either H-PAC or L-PAC added to the feed.  
The same dosages were used in two replicate trials.  For each trial, all birds were given feed 
supplemented with H-PAC or L-PAC, except for positive Campylobacter controls, starting at 
day of placement and continuing through the entire 14 day trial.  At day 7 all birds were 
challenged with a mixture of three wild type Campylobacter jejuni strains by oral gavage 
(approximately 2.5 x10
5
 cfu/mL).  On day 14, birds were euthanized by CO2 and cecal contents 
were collected for enumeration of Campylobacter.  In both trials cecal Campylobacter counts 
were not reduced by administration of L-PAC or H-PAC in the feed.  Follow up experiments are 
needed to increase the potency of these cranberry extracts to reduce this important food borne 
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CHAPTER 1: LITERATURE REVIEW 
 
1.1 Introduction 
One of the leading bacterial causes of food borne illness worldwide is contamination of food 
products by thermophilic Campylobacter spp.  In many nations, programs have been developed 
to try to determine the potential disease burden caused by known food borne pathogens.  In the 
United States, the Centers for Disease Control (CDC) estimates that yearly, Campylobacter spp. 
is responsible for approximately 850,000 food related illnesses (Scallan et al., 2011).  The 
European Food Safety Authority (EFSA), which provides food borne illness data from its twenty 
seven Member States, estimates that annually Campylobacter spp. causes 9 million illnesses in 
the European Union (European Food Safety Authority, 2011b).  Poultry products have been cited 
as the leading cause of human campylobacteriosis in developed countries (Rosenquist et al., 
2003; Friedman et al., 2004; World Health Organization, 2009; European Food Safety Authority, 
2010a).  Source attribution and case control studies have indicated that the most frequent cause 
of human infection with Campylobacter are eating improperly cooked chicken, handling chicken 
and exposure to animals including poultry (Friedman et al., 2004; Danis et al., 2009; Lindmark et 
al., 2009; Fajó-Pascual et al., 2010).  Campylobacter jejuni is the species most frequently 
identified from food borne campylobacteriosis cases (European Food Safety Authority, 2011b). 
1.2  Characteristics of Campylobacter 
1.2.1  Historical Overview 
The family Campylobacteraceae consists of the genus Campylobacter and related genera 
including but not limited to Helicobacter, Wolinella, Sulfurospirillum, and Arcobacter 
(Debruyne et al., 2008). There are currently at least 17 identified species of Campylobacter, but 
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the number is expected to grow due to the continual identification of new species, aided by the 
advent of new molecular detection and identification tools (Lawson et al., 1998; Debruyne et al., 
2008).  Campylobacter spp. were first isolated and described in 1906 by McFayden during his 
investigation into increased rates of abortion in sheep and cattle due to an unknown agent 
(Skirrow, 2006).  It was several years later, in 1919, that Smith and Taylor first classified the 
veterinary pathogen as Vibrio fetus and not until 1963 that the genus of Campylobacter was 
designated (Smith and Taylor, 1919; Sebald and Veron, 1963).  Further classification of the 
Vibrio like organisms into the type species C. fetus along with C. coli, C. jejuni, and C. sputorum 
was proposed in 1973 by Vêron and Chatelain owing to its differing characteristics from the 
genus Vibrio (Veron and Chatelain, 1973; Butzler, 2004).  Campylobacter spp. has risen from 
obscure veterinary pathogen that causes abortion and enteritis in livestock, to the leading 
etiological agent of food borne illness in the developed world (European Food Safety Authority, 
2011b; Scallan et al., 2011).  Our understanding of the nature and abundance of Campylobacter 
with regards to human illness and food safety has evolved over the last 40 years principally due 
to pioneering researchers that developed isolation and identification methodologies for this 
relatively fastidious organism (Dekeyser et al., 1972; Skirrow, 1977). 
1.2.2 Morphology and In Vitro Culture Conditions 
The family Campylobacteraceae is composed of small (0.2 to 0.8µm) curved or S-
shaped, non-spore forming Gram negative rods with a single polar flagella at one or both ends of 
the cell (Debruyne et al., 2008).  Its morphology is known to evolve from spiral form to coccoid 
depending upon age of the culture and external environmental conditions (Griffiths, 1993; 
Debruyne et al., 2008).  Members of the genus Campylobacter require reduced oxygen, 
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microaerobic atmosphere for growth and the primary human disease causing species, C. jejuni 
and C. coli, are thermophiles whose optimum temperature for growth is 42
0 
C (King, 1957; King, 
1962). 
1.2.3 Genetic Diversity 
A characteristic of Campylobacter spp. that has been frustrating and challenging 
researchers alike is the extensive amount of strain variability of this organism.  Research in the 
phenotypic characteristics of C. jejuni have shown it to express wide ranging rates of 
invasiveness into host cell lines, chicken cell lines, and toxin produced (Hu and Kopecko, 1999).  
Efforts have been made to better understand these variations and the use of whole genome 
sequencing technologies and microarray based assays are being employed to investigate the 
genetic diversity within the genus.  The first whole genome molecular analysis of C. jejuni was 
performed by Parkhill, and from that work it was determined that C. jejuni has a circular 
chromosome of approximately 1.6Kb rich in A+T (~70% A+T) (Parkhill and Wren, 2000).  Also 
noted upon analysis of the whole genome were the following: (1) the lack of presence of 
transposons; (2) traces of phage integration in the chromosome; (3) lack of other commonly 
utilized molecular mechanisms for gaining new genetic material such as insertion elements; and 
(4) few number of repeat sequences (Parkhill and Wren, 2000).  Following the first whole 
genome sequence of Campylobacter jejuni strain NCTC11168, many other strains have since 
been sequenced and their genome information is freely available for use in further research.  The 
availability of multiple genome sequences has enabled researchers to utilize microarray 
technology for multiple strain comparisons at the molecular level (Dorrell et al., 2001; Pearson et 
al., 2003; Parker et al., 2006; Duong and Konkel, 2009).  From these multiple strain 
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comparisons, researchers have identified areas within the Campylobacter genome with the 
potential to generate the high degree of diversity that is notable within this genus.  Areas found 
include hypervariable plasticity regions, of which seven have been identified so far, and they are 
believed to contain approximately 50% of the genes involved in generating genomic diversity 
(Pearson et al., 2003).  Genes contained within the plasticity regions are believed to be mostly 
dispensable within the Campylobacter spp. genome, with functional activity including the 
modification of flagellar, outer membrane, and periplasmic proteins along with the ability to 
accept alternative electron sources (Pearson et al., 2003).  During Parkhill’s first analysis of the 
Campylobacter NCTC 11168 genome, it was noted that it contained homopolymeric tracts of 
nucleotides which have since been traced to hypervariable or plasticity regions (Parkhill and 
Wren, 2000; Pearson et al., 2003).  It is suggested that these homopolymeric runs of nucleotides 
may work as a mechanism in phase variation to turn genes on or off leading to the large amount 
of strain diversity that is a hallmark of Campylobacter. 
1.2.4 Environmental Reservoirs 
Campylobacter spp. are widespread in the environment, they do however require a warm 
blooded host to carry out their processes of replication and are therefore common flora of wild 
and domestic animals and birds (Ketley, 1997).  Although Campylobacter is currently regarded 
as a natural inhabitant of the avian gut microbiota, historically it has been implicated in poultry 
disease including vibrionic hepatitis and shown to be capable of inducing diarrhea in a chicken 
model (King, 1962; Smibert, 1978; Ruiz-Palacios et al., 1981; Achen et al., 1998).  
Environmental and non-animal sources of Campylobacter spp. include, but are not limited to, 
surface water, abattoir effluent, non-pasteurized milk, shellfish, sand and protozoans; where the 
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organism can persist for extended periods if given the favorable environment of protection from 
direct sunlight and cool moist atmosphere (Jones, 2001; Skelly and Weinstein, 2003; Axelsson-
Olsson et al., 2005; European Food Safety Authority, 2010c). 
1.2.5 Viable But Non Culturable (VNBC) 
Although Campylobacter spp. has particular requirements for its continual colonization 
within suitable hosts and may be considered a more ‘fragile’ organism, it also posses the 
capability to withstand environmental stressors during transmission from one host to another.  
During the transition from host to host Campylobacter spp. must endure unfavorable 
environmental conditions such as increased oxygen, temperature fluctuations and varying levels 
of moisture, all of which prior research has demonstrated inhibits its proliferation and survival 
(Park, 2002).  One potential mechanism that Campylobacter may utilize for survival during 
periods of stress is the conversion to a viable but nonculturable (VNBC) state (Rollins and 
Colwell, 1986; Meinersmann et al., 1991).  VNBC is an alteration of the bacterium from an 
active state of growth and metabolism to one of dormancy leading to minimal metabolism and no 
reproducibility, however viability can be restored under favorable conditions (Oliver, 2005; 
Oliver, 2010).  However the role of this VNBC state and its impact as an environmental reservoir 
for the continual dissemination of Campylobacter remains to be determined (Svensson et al., 
2008). 
1.2.6 Mechanisms of Pathogenesis 
Research on other frequent food borne bacterial pathogens that produce enteritis, such as 
Salmonella enterica  and Escherichia coli, have shown that the production of protein toxins are 
intimately involved in inducing diarrhea, and therefore it could be expected that Campylobacter 
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spp. may also produce protein toxins (Pickett, 2000).  The exact virulence mechanisms for the 
pathogenesis of Campylobacter spp. however still remain to be fully understood.  Upon 
sequencing of the genomes of several strains of C. jejuni and performing comparisons to other 
enteric pathogens, it was determined that C. jejuni does not encode genes that are homologous to 
commonly associated virulence factors such as enterotoxins, adhesions, invasions or 
pathogenicity islands (Parkhill and Wren, 2000; Eppinger et al., 2004; Fouts et al., 2005; 
Hofreuter et al., 2006).  Research has shown that Campylobacter jejuni adheres to intestinal 
epithelial cells leading to the translocation of the bacterium across the mucosal layer and 
internalization into epithelial cells (Hu and Kopecko, 2008; Watson and Galan, 2008).  Some 
Campylobacter strains do posses a gene cluster that encodes a multi-subunit toxin, named 
cytolethal distending toxin (CDT), but its function in relation to pathogenesis is not clear 
(AbuOun et al., 2005; Asakura et al., 2007).  Even with limited knowledge of the mechanisms of 
action for Campylobacter pathogenesis, it is generally recognized that there are five main 
components of Campylobacter pathogenicity, consisting of motility, adherence, invasion, 
production of toxins, intracellular survivability and secretion of specialized proteins (Larson et 
al., 2008).  
1.3 Human Infection 
With the development and introduction of sensitive and specific laboratory methods to 
isolate and identify Campylobacter spp. from human samples, a more accurate assessment of the 
disease burden caused by this zoonotic organism has been shown.  Starting in the early 1980’s, at 
which time it was considered an emerging food borne pathogen, and continuing to the present, 
Campylobacter spp. remains a primary agent for human enteritis in the United States (Blaser et 
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al., 1983; Altekruse et al., 1999; Centers for Disease Control and Prevention, 2006; Matyas et al., 
2010).  It is now recognized that human infection with Campylobacter spp. is one of the leading 
causes of acute bacterial gastroenteritis in developed nations throughout the world (Olson et al., 
2008; European Food Safety Authority, 2011b).  Human infection with Campylobacter, leading 
to campylobacteriosis, are caused by the thermophilic members of the Campylobacter genus; C. 
jejuni, C. coli, C. lari, C. upsaliensis and C. helveticus.  Campylobacter jejuni and C. coli are the 
two species most frequently identified in association with food borne illness, epidemiologic 
studies have indicated that infection with C. jejuni is most frequent (>80%) and infection with C. 
coli occurs at a much lower level (~10%) (European Food Safety Authority, 2011a; European 
Food Safety Authority, 2011b).  Initial studies described that ingestion of as few as 500-800cfu 
of Campylobacter can result in illness onset (Robinson, 1981; Black et al., 1988).  Further 
investigation into the number of Campylobacter required to elicit illness has demonstrated that 
the true infective dose is more elusive, and is dependent upon other criteria such as the traits of 
the particular strain and the immune status of the host (Newell, 2002).  General characteristics of 
campylobacteriosis include rapid onset of abdominal cramping and diarrhea lasting on average 7 
days, initiated after an average incubation period of 3 days from time of exposure, with 30% of 
persons infected having general malaise and fever before diarrheal onset (Blaser, 1997; Blaser 
and Engberg, 2008).  It has been noted that diarrhea caused by Campylobacter generally 
manifests in one of two ways; non-inflammatory diarrhea in which the stool is watery with no 
presence of white blood cells and red blood cells or inflammatory diarrhea in which the fecal 
material contains red and white blood cells (Wassenaar, 1997).  Severe abdominal cramping has 
been known to lead to the misdiagnosis of appendicitis, however Campylobacter spp. is capable 
of extraintestinal infection of the gallbladder, pancreas, appendix and bacteremia (Blaser, 1997; 
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Blaser and Engberg, 2008).  Antibiotic treatment is usually unwarranted but depending upon the 
severity of the symptoms antimicrobial therapy may be administered.  Campylobacter spp. may 
be continually shed in the feces for up to three weeks, but there is documentation of its presence 
for up to 69 days (Kapperud et al., 1992).  Infection with Campylobacter spp. is capable of 
causing late onset morbidity such as Guillain-Barré syndrome, reactive arthritis and irritable 
bowel syndrome. 
1.3.1 Guillain-Barré Syndrome  
Most frequently campylobacteriosis is an acute self-limiting illness, but a certain 
percentage of those afflicted will develop Guillain-Barré syndrome (GBS).  It is a post-infectious 
neurological syndrome that manifests as weakness and tingling in the extremities and proceeds to 
ascending symmetrical paralysis potentially requiring medical interventions to support life 
(Allos, 1997).  Due to the global vaccination programs that have almost completely eradicated 
poliomyelitis virus, GBS has become the primary cause of acute flaccid paralysis (Allos, 1997; 
Jacobs et al., 2008).  The connection between Campylobacter spp. and Guillain-Barré was first 
suspected in the early 1980’s and in the last 30 years evidence has indicated that between 30% - 
40% of patients with GBS had an infection with Campylobacter spp. preceding the onset of GBS 
(Rhodes and Tattersfield, 1982; Mishu and Blaser, 1993; Allos, 1997; Jacobs et al., 2008).  The 
onset of GBS symptoms usually occur between 10 days to 3 weeks after the diarrheal stage of 
Campylobacter infection (Blaser and Engberg, 2008).  Research into the mode of action for the 
development of GBS has focused on the immune systems production of cross-reactive 
antibodies, in response to Campylobacter infection, that then proceed to attack the myelin sheath 
covering peripheral nerve tissue, leading to paralysis (Jacobs et al., 2008).  During infection with 
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Campylobcter there exists the potential for production of autoantibodies that bind to GM1 
ganglions contained within the plasma membranes of Schwann cells that make up the myelin 
sheath covering axons (Yuki et al., 1993; Yuki et al., 2004).  These autoantibodies bind to the 
GM1 ganglions and elicit a recruitment of complement components and macrophage that break 
down the myelin sheath (Oomes et al., 1995).  The duration of symptoms may last for weeks, 
with the greatest amount of peripheral nerve paralysis generally occurring between 2-3 weeks 
after onset of symptoms, after which time recovery begins (Nachamkin et al., 2000; van 
Koningsveld et al., 2007).  Although the disease is considered self-limiting, due to the 
involvement of respiratory nerves, a large proportion of cases require the use of a ventilator 
(Jacobs et al., 2008).  Recovery is slow and progresses over weeks to months with up to 20% of 
patients having some lasting physical disability (van Koningsveld et al., 2007; Jacobs et al., 
2008). 
1.3.2 Reactive Arthritis 
Reactive arthritis (ReA) is a poorly defined disease characterized by sterile joint 
inflammation and potential inflammation of other sites including tendons, eyes and skin (Pope et 
al., 2007; Townes, 2010).  The association between ReA and Campylobacter infection was first 
noted in the 1970’s and to this day the true incidence and consequent health impacts remain to be 
determined (Gumpel et al., 1981; Pope et al., 2007).  It has been estimated that ReA potentially 
arises in 1% - 5% of persons sickened by Campylobacter, with symptoms of ReA generally 
occurring on average of 14 days post-onset of Campylobacter associated diarrhea (Peterson, 
1994; Pope et al., 2007).  The course of symptoms from ReA can persist for several weeks to 
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months after which time persons fully recover, however chronic inflammation lasting longer 
periods has been documented (Blaser and Engberg, 2008; Garg et al., 2008). 
1.3.3 Irritable Bowel Syndrome & Inflammatory Bowel Disease 
Irritable bowel syndrome is a complication that can occur after infection with bacterial 
agents that cause gastroenteritis, such as Campylobacter spp. (Smith and Bayles, 2007; Spiller, 
2007).  Common causes of food borne illness, including Campylobacter spp. may induce 
irritable bowel syndrome, however the rates of persons affected by IBS following 
campylobacteriosis are not as yet known (Gilkin, 2005).  In general, the amount of time to return 
to normal bowel function following an episode of IBS is lengthy, with one follow up study 
showing data that 5 years after onset of IBS 50% of persons still had symptoms (Spiller, 2007).  
Campylobacter infection has also been linked to the development of inflammatory bowel disease 
(IBD) (Gradel et al., 2009).  The current theory is that the body, for unknown reasons, loses 
immunological tolerance to commensal organisms within the gut leading to chronic immune 
system stimulation within the gastrointestinal tract (Maul and Duchmann, 2008).  
Campylobacter’s role in IBD is still not fully understood.  A potential mechanism by which 
Campylobacter facilitates the symptoms of IBD is by its ability to translocate normal gut 
microflora across the intestinal epithelium leading to the inappropriate activation of T-cells 
(Kalischuk et al., 2009; Kalischuk et al., 2010). 
1.4 Campylobacter spp. in Poultry 
The capability of poultry to serve as a natural reservoir for thermophilic Campylobacter 
spp. is commonly believed to be due in part to their ability to reside within the gut microbiota as 
a commensal and the average avian body temperature of 41.8
0
C is optimum for growth of the 
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bacteria (Horrocks et al., 2009; Hermans et al., 2012).  Infection studies performed with poultry 
demonstrate that Campylobacter primarily colonize the lower parts of the gastrointestinal tract 
with a preference for the cypts within the ceca (Beery et al., 1988; Meinersmann et al., 1991; 
Achen et al., 1998).  The concentration of Campylobacter spp. within the ceca of chickens is 




 cfu per gram of cecal 
contents (Evans, 1992; Stern et al., 1995; Cawthraw et al., 1996).  Campylobacter spp. are 
chemoattracted to mucin, which can serve as a source of energy, and this may explain its 
predilection for colonizing within the mucus filled cecal crypts (Beery et al., 1988; Hugdahl et 
al., 1988).  The ceca of the chicken is a dynamic environment, contractile movements frequently 
occur to mix the contents and also expel them as necessary (Clench, 1999).  The exact 
mechanisms by which Campylobacter is able to maintain a presence within this constantly 
moving environment is not yet fully understood.  Although Campylobacter is predominantly 
found within the cecal crypts several studies have shown that it is capable of extraintestinal 
invasion of other organs including the liver and spleen (Young et al., 1999; Meade et al., 2009).  
In vivo testing demonstrated that inoculation and subsequent colonization of the ceca of chickens 
with Campylobacter spp. does not lead to host tissue pathology or increased morbidity and 
mortality (Dhillon et al., 2006; Smith et al., 2008). 
1.4.1 Commensalism 
Due to the lack of host cell pathology and symptoms of disease Campylobacter is 
frequently termed as a commensal organism within the gut microbiota of poultry.  The role of 
Campylobacter as a commensal organism within poultry is not definitive.  Work by Meade and 
coworkers (2009) which investigated gene expression profiles of the immune response of chicks 
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following inoculation with C. jejuni, showed that C. jejuni is capable of eliciting a response of 
the chick immune system, albeit not strongly, and subsequent down regulation of several genes 
that produce antimicrobial peptides.  Therefore, the persistent presence of Campylobacter and its 
high cell density within the ceca may be the result of Campylobacters ability to modulate the 
immune response of the chicken (Van Deun et al., 2008; Meade et al., 2009; Shaughnessy et al., 
2009).  The ability of Campylobacter to invade chicken intestinal epithelial cells is also a subject 
of some discord.  Initial work done by Beery and coworkers (1988) demonstrated no 
internalization of C. jejuni into the intestinal mucosa, but later research by Van Deun and 
coworkers (2008) has demonstrated C. jejuni’s ability to temporally invade and then exit the 
epithelial cells.  It is proposed that Campylobacter may avoid cecal crypt removal by a process 
of invading crypt epithelial cells briefly then exiting back into the mucus layer followed by 
replication in the mucus (Van Deun et al., 2008).  More recent studies have shown that 
Campylobacter does express adhesion proteins and that they play a role in the successful 
colonization of chickens, so interaction with the surface of intestinal epithelial cells potentially 
does occur at some point during colonization (Ziprin et al., 1999; Ashgar et al., 2007; Flanagan 
et al., 2009).  Ultimately, the colonization of the chicken gastrointestinal tract by Campylobacter 
is dictated by many host and bacterial factors whose mechanisms require more research to be 
fully understood. 
1.4.2 Incidence in Poultry 
Surveys done to try to ascertain the percent of commercial poultry flocks positive for 
Campylobacter spp. found counts to be highly variable; with rates in EU member states between 
2-100% and rates in the U.S. to upwards of 90% (Humphrey et al., 1993; Stern et al., 2001b; 
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European Food Safety Authority, 2010b).  Studies have shown that commercial poultry typically 
become positive for the presence of Campylobacter between 2-3 weeks of age (Gregory et al., 
1997; Wagenaar et al., 2008).  Chickens become rapidly colonized and may shed Campylobacter 
in droppings within 24 hours of initial exposure, after which time the spread of Campylobacter 
through the flock is estimated to be approximately 2 new cases per colonized bird per day 
(Achen et al., 1998; Gerwe et al., 2005; Knudsen et al., 2006).  The infective dose required for 
host colonization is strain variable, however successful colonization of poultry has been 
established with inoculum concentrations as low as 10 CFU/g after which time the 
Campylobacter concentration within the cecum may reach levels of 10
9
 CFU/g at time of 
slaughter (Shanker et al., 1988; Newell et al., 2000; Chen et al., 2006; Line et al., 2008a).  
Contamination of the rearing environment from Campylobacter positive birds and the 
subsequent rapid transmission among the flock leads to the incidence of Campylobacter positive 
flocks estimated at between 60% -100% worldwide (Stern et al., 2001b; Herman et al., 2003; 
European Food Safety Authority, 2010b). 
1.4.3 Horizontal Transmission 
The mode of transmission of Campylobacter spp. to commercial poultry flocks is 
believed to be primarily through horizontal transmission due to the presence of bacteria in the 
farm environment, on and in such things as equipment, footwear, standing water and vectors 
including flies, mice and wild birds (Hiett et al., 2002; Herman et al., 2003; Wagenaar et al., 
2008).  Analysis into the impact of potential environmental sources for the horizontal 
transmission of Campylobacter have found that insect vectors, such as flies and Darkling 
Beetles, have a high rate of testing positive for Campylobacter and are therefore a potential 
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source for the spread of the bacterium throughout the farm (Rosef and Kapperud, 1983; Bates et 
al., 2004; European Food Safety Authority, 2011b).  Research performed on commercial broiler 
flocks positive for Campylobacter indicate that multiple strains may circulate within the flock, 
which may play a part in increasing strain diversity (Jacobs-Reitsma et al., 1995; Ellerbroek et 
al., 2010). 
1.4.4 Vertical Transmission 
The role of vertical transmission of Campylobacter among poultry and its potential 
impact is an area of much debate.  Research has demonstrated that the reproductive tissues of 
hens and their reproductive tract may be colonized with Campylobacter leading to contamination 
during egg development (Hiett et al., 2003).  The presence of Campylobacter within semen from 
breeder roosters and toms has also been confirmed and serves as a potential route for 
transmission to the breeder hen (Cox et al., 2002; Donoghue et al., 2004; Cox et al., 2005).  A 
potential secondary mechanism for Campylobacter contamination of eggs is by fecal material in 
contact with the shell of the egg upon lay, after which time it must penetrate the shell and remain 
vegetative until hatching of the chick (Sahin et al., 2003).  Work done to determine the 
significance of Campylobacter contaminated eggs has shown that hens testing positive for 
Campylobacter rarely produce eggs that test positive (Doyle, 1984; Shanker et al., 1986; Sahin et 
al., 2003).  Research into the ability of Campylobacter to survive on the shell and penetrate to the 
albumen revealed that Campylobacter remained on the surface for a maximum of 16 hours and 
was sensitive to the drying of the shell and increased oxygen levels (Shane et al., 1986).  The 
ability of Campylobacter to stay viable in the albumen and airsac within the egg has been studied 
and results show it is unable to survive for periods longer than 8 days, potentially due to the 
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oxygen concentrations, increased pH levels and inhibitory substances (Sahin et al., 2003).  
Commercially, table eggs and hatching eggs are stored at refrigerated temperatures which may 
also contribute to low contamination levels (Clark and Bueschkens, 1986).  A potential source 
for Campylobacter viability within the egg is by contamination of the yolk, where studies have 
shown it to survive for up to 14 days (Sahin et al., 2003).  Though the presence of 
Campylobacter has been confirmed within the reproductive tracts of poultry, evidence for this 
route of transmission as having a significant impact upon colonization status in subsequent 
progeny flocks has not been demonstrated (Sahin et al., 2003). 
1.5 Methods of Pre-harvest Intervention 
Exposure to Campylobacter through contact with poultry and poultry products has been 
determined to be the leading cause of human campylobacteriosis in the United States and in 
Europe (Friedman et al., 2004; European Food Safety Authority, 2011b).  The European Food 
Safety Authority has determined that approximately 20% - 30% of human campylobacteriosis is 
caused from inadequate handling, preparation and subsequent consumption of chicken meat, and 
50%-80% of campylobacteriosis cases are related to contact with poultry and poultry products in 
general (European Food Safety Authority, 2010c).  In Belgium during a temporary ban on 
consumption of poultry due to dioxin contamination, the rates of campylobacteriosis infection in 
humans dropped by approximately 40%, further establishing the link between poultry and human 
Campylobacter infection (Vellinga and van Loock, 2002).  In May of 2010 the United States 
Department of Agriculture (USDA) announce a new monitoring program for the presence of 
Campylobacter on young chicken and young turkey carcasses (Food Safety and Inspection 
Service, 2011c).  Initial baseline surveys performed by USDA indicated that level of 
16 
 
Campylobacter contamination of young chicken and turkey carcasses was 46% and 1% 
respectively, and from this data the new performance standards have been set at 10.4% for 
chicken and 0.79% for turkey (Food Safety and Inspection Service, 2011a; Food Safety and 
Inspection Service, 2011c; Food Safety and Inspection Service, 2011d).  The USDA expects a 
reduction of approximately 5,000 incidents of food borne related Campylobacter infections 
according to analysis done by the USDA’s Risk Assessment Division (Food Safety and 
Inspection Service, 2011b).  Much emphasis has been placed on preharvest strategies for the 
elimination of Campylobacter in poultry.  Risk assessment studies have indicated that a 
reduction by 3 logs of Campylobacter in the gastrointestinal tract of chickens would have a 
significant public health impact, with estimates of a potentially 90% reduction of public health 
risks from Campylobacter (European Food Safety Authority, 2011b).  Strategies for eliminating 
Campylobacter colonization in poultry can be broadly grouped into three approaches, consisting 
of (1) increased biosecurity to limit the birds exposure to potential environmental sources (Adkin 
et al., 2006; Wagenaar et al., 2008), (2) utilization of naturally produced molecules from bacteria 
that have antibacterial activity against Campylobacter such as bacteriocins and bacteriophages 
(Carrillo et al., 2005; Stern et al., 2005; Svetoch et al., 2005; Wagenaar et al, 2005) and (3) 
strategy is to use methods to prevent colonization of the ceca including vaccination, probiotic 
treatments and administration of natural compounds (Newell and Wagenaar, 2000; Stern et al., 
2001a; Zoete et al., 2007; Lin, 2009; Solis de los Santos et al., 2010; Molatova et al., 2011). 
1.5.1 Biosecurity 
Biosecurity is a strategy of preventative actions implemented to reduce the potential for 
transmission of infectious organisms from a reservoir to a potential host (European Food Safety 
Authority, 2011b).  Thus, the implementation of strict biosecurity protocols on the farm may be 
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used to try to prevent the initial exposure of the birds to Campylobacter.  The impact of 
biosecurity measures has been studied with results implicating unsatisfactory biosecurity as the 
greatest contributor to Campylobacter transmission to commercial poultry (Adkin et al., 2006).  
Due to horizontal transmission of Campylobacter to poultry as the main mechanism for flock 
colonization, the hygiene practices of workers on the farm play a significant role (Newell et al., 
2011).  Some potential difficulties regarding increased on farm biosecurity include the lack of 
clearly defined relative risk contributions for specific environmental factors (Carrillo et al., 2005; 
Wagenaar et al., 2008).  However, with the vast number of potential environmental sources and 
the needs within commercial poultry production for interaction with the flock, implementation of 
very strict biosecurity measures may not be feasible (Wagenaar et al., 2008). 
1.5.2 Bacteriocin 
One strategy that is being investigated for the elimination of Campylobacter colonization 
in poultry is the administration of bacteriocins.  Bacteriocins are small peptides of approximately 
5 to 6kDa that are produced by bacteria and are toxigenic to bacteria other than the producer 
strain; their function is as a defense mechanism (Klaenhammer, 1993; Nes et al., 1996).  
Research into bacteriocins has determined that the most common genera of bacteria that produce 
antimicrobial peptides which may have some applicability to poultry include Lactobacillus, 
Lactococcus and Bacillus, however many other genera also produce these compounds (Svetoch 
and Stern, 2010).  Svetoch and coworkers (2005) investigated the normal gut flora of poultry as a 
source for bacteria producing anti-Campylobacter peptides and successfully purified and 
characterized bacteriocins from strains of Bacillus circulans and Paenibacillus polymyxa.  In 
vivo experiments with anti-Campylobacter bacteriocins when administered to poultry have 
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demonstrated efficacy to significantly reduce Campylobacter colonization within the 
gastrointestinal tract to levels below the detection limit (Stern et al., 2005; Cole et al., 2006b; 
Stern et al., 2006; Line et al., 2008b; Svetoch et al., 2008).  Commercial usage of bacteriocins for 
the control of Campylobacter in poultry is limited by the labor and expense of production and 
concerns regarding development of resistance and toxicity to the host and consumer (Lin, 2009).  
With regards to toxicity, the risks of bacteriocins are regarded as minimal; they are produced by 
bacteria in commonly consumed food products including cheese and yogurt and are likely also 
produced by commensal bacteria contained within the human gut (Cleveland et al., 2001; 
Svetoch and Stern, 2010).  There is concern of developing bacteriocin resistant strains of 
Campylobacter in response to their being used therapeutically.  Hoang and coworkers (2011b) 
screened a collection of Campylobacter jejuni isolates from multiple sources and found that only 
one isolate of the 146 tested displayed some level of resistance.  Limited in vitro testing in 
poultry for determining rates of resistance development after treatment with a bacteriocin (E-
760) indicated that a low level resistance was present after administration of the bacteriocin, but 
levels of resistance never increased during the trial, indicating mechanisms for development of 
resistance to bacteriocins may not be highly developed (Peschel and Sahl, 2006; Hoang et al., 
2011a).  Another potential hurdle for implementation of bacteriocins to control Campylobacter 
in poultry is the process of obtaining regulatory approval, which potentially requires extensive 
studies of efficacy and toxicity along with the requisite application process.   
1.5.3 Bacteriophage 
Control of Campylobacter in the chicken gastrointestinal tract and upon retail poultry 
products by the introduction of anti-Campylobacter viruses is a potential treatment option that is 
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being investigated for commercial use (Connerton et al., 2008).  Viruses which infect bacteria 
and require a bacterial host for replication and dissemination are named as bacteriophage.  These 
infectious viruses may have a very narrow range of bacterial hosts to which they infect, some of 
which are single strain specific.  Cytophathic effects on the host organism caused by infection of 
lytic bacteriophage, subsequent multiplication and mechanisms for virus spread ultimately lead 
to lysis of the host cell (Joerger, 2003).  Bacteriophage are ubiquitous in nature and 
Campylobacter specific bacteriophage have been isolated from multiple sources, including 
poultry intestinal microbiota, retail poultry products, processing plant wastewater, and manure 
from other livestock including cattle, pigs and sheep (Grajewski et al., 1985; Salama et al., 1989; 
Khakhria and Lior, 1992; Atterbury et al., 2003; Carrillo et al., 2005).  Limited research on the 
application of bacteriophage to broiler chickens for the reduction of cecal carriage of 
Campylobacter has demonstrated the capability of this strategy, rates of reduction for 
Campylobacter were between 1-5 logs (Carrillo et al., 2005; Wagenaar et al., 2005).  The 
implementation of bacteriophage based interventions face several technical challenges.  
Researchers believe that significant factors influencing the efficacy of bacteriophage against 
Campylobacter include the selection of specific bacteriophage, the bacteriophage and host strain 
interaction, and ascertainment of optimal dosages (Carrillo et al., 2005; Wagenaar et al., 2005; 
Connerton et al., 2008).  The potential for development of bacteriophage resistant 
Campylobacter strains is also of concern in regards to its commercial application (Connerton et 
al., 2008).  Carrillo and coworkers (2005) reported isolation of Campylobacter resistant to the 
therapeutic bacteriophage administered during an in vivo trial, however it was noted that the 
resistant strain was not the predominant phenotype isolated and the resistant strain when re-
administered to poultry reverted to a sensitive phenotype.  In regards to development of resistant 
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strains it has been suggested that due to the environmental exposure to multiple strains of 
Campylobacter in poultry, it is feasible that during bacteriophage treatment an environmental 
isolate insensitive to the administered bacteriophage could become dominant instead of a 
resistant strain being created by selective pressure (Connerton et al., 2004). 
1.5.4 Vaccination 
Within commercial production of poultry the use of vaccination to prevent the infection 
and spread of some disease causing microorganisms is already established.  Currently however 
there are no commercial vaccines available for the prevention of Campylobacter infection in 
poultry (Wagenaar et al., 2008; Lin, 2009).  Important challenges to developing a vaccine 
include the nature of colonization of Campylobacter in poultry, our relative lack of 
understanding in regards to the avian immune system, the identification of conserved regions 
among Campylobacter that may serve as antigenic targets, and the short lifespan of broilers that 
therefore have relatively immature immune system development (Zoete et al., 2007; Lin, 2009).  
Zoete and coworkers (2007) have proposed that a proper Campylobacter candidate vaccine must 
include several parameters: (1) broad specificity to induce protection against multiple 
Campylobacter subtypes, due to the early exposure of birds to Campylobacter in the rearing 
environment; (2) the generation of a protective immune response must be generated quickly post 
vaccination and (3) the vaccination must be cost-effective and easily administered.  Research on 
the interaction of Campylobacter and the avian immune system has demonstrated that 
Campylobacter specific antibodies are present upon challenge and therefore an antibody 
mediated mechanism due to vaccination is a possibility (Myszewski and Stern, 1990; Cawthraw 
et al., 1994; Widders et al., 1996; Rice et al., 1997).  In a review of candidate vaccines by Zoete 
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and coworkers (2007) the results of various vaccination strategies were analyzed and they found 
that inactivated and heat killed C.jejuni vaccines provided little protection (approximately 1-2 
log reduction in cecal counts) and recombinant vaccines in which an antigenic Campylobacter 
protein is expressed had between 2-6 log reductions in cecal colonization after homologous 
strain challenge.  The mechanisms by which Campylobacter generates its extensive genotypic 
and phenotypic diversity contribute greatly to the difficulty of creating a vaccine with 
heterologous protective effects (Zoete et al., 2007; Wagenaar et al., 2008).  So the challenge still 
remains to produce a vaccine capable of inducing a strong immune response that inhibits 
colonization or leads to a significant reduction of Campylobacter colonization within poultry, 
that is easily administered and inexpensive (Zoete et al., 2007) 
1.5.5 Probiotics and Competitive Exclusion 
The supplementation of diet with beneficial microorganisms to potentially improve the 
health of the host, so called probiotic treatment is a strategy under investigation for control of 
Campylobacter in poultry (Fuller, 1989; Joint Food and Agriculture Organization, 2006; 
Wagenaar et al., 2008).  The goal of the use of probiotics in poultry is to attempt to prevent 
colonization or alter the gut microflora so as to inhibit establishment of unwanted or detrimental 
bacteria by administration of helpful or beneficial bacteria (Metchnikoff and Mitchell, 1910; 
Wagenaar et al., 2008).  The most frequently used bacterial genus for use as probiotics include 
Lactobacillus, Bacillus, Lactococcus, Bifidobacterium and Streptococcus (Fooks and Gibson, 
2002; Lutful Kabir, 2009).  One application of probiotic usage within the poultry industry is as a 
component of defined cultures during competitive exclusion treatments to prevent colonization 
of Campylobacter in newly hatched chicks (Cox and Pavic, 2010).  The principal of competitive 
22 
 
exclusion (CE) is based upon work by Nurmi and Rantala (1973) who associated the direct 
feeding of healthy adult chicken intestinal flora to newly hatched chicks with the lack of 
Salmonella infantis colonization within the chick gastrointestinal system (Nurmi and Rantala, 
1973; Rantala and Nurmi, 1973).  Research into the potential mechanisms of action for the 
positive effects of competitive exclusion treatments have led to several proposed ideas, including 
competition between CE organisms and the undesirable organisms for sites to colonize within 
the niche environment and competition for nutrients, the production of bacteriocins and volatile 
fatty acids inhibitory to the target organisms and the potential modulation of host immune cell 
interactions with the gut microbiota (Koenen et al., 2004; Schneitz, 2005; Doyle and Erickson, 
2006).  The results of in vivo trials to evaluate the ability of probiotic strains of bacteria to 
eliminate Campylobacter colonization of the ceca have yielded inconsistent results.  Work by 
Stern an coworkers (2001a) in which they harvested mucosally derived probiotic organisms for a 
CE treatment found that by administering the treatment to day of hatch chicks and artificially 
inoculating the chicks with Campylobacter 24 hours later they were able to achieve a statistically 
significant reduction in Campylobacter colonization, but it was noted that the overall effective 
protection afforded by this treatment was very low.  Several in vivo trials which utilized poultry 
derived probiotic cultures as a competitive exclusion treatment have demonstrated the ability to 
reduce fecal shedding and cecal colonization but were unable to prevent to colonization of the 
ceca (Aho et al., 1991; Morishita et al., 1997; Newell and Wagenaar, 2000).   
1.5.6 Natural Compounds 
The rise in interest of natural compounds, including plant extracts, for improvement of poultry 
health and disease treatment has followed the general trend in the United States of increased 
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demand for organic poultry and increased pressure on commercial producers to eliminate use the 
use of arsenicals, growth promoters and antibiotics.  This poses a significant challenge for 
producers of food animals to find alternatives for the aforementioned compounds but not 
increase rates of disease and maintain efficient and cost effective production practices (Tillman 
et al., 2011).  Research into the use of naturally derived compounds for control of pathogens in 
poultry is limited.  However preliminary data has demonstrated efficacy with administration of 
medium chain fatty acids, and the use of plant extracts is also being investigated. 
1.5.7 Medium Chain Fatty Acids 
Fatty acids are composed of long chains of carbon atoms with attached hydrogen atoms 
and can be classified based upon the length of the carbon chain.  Fatty acids are present in animal 
and vegetable fats and are a component of the body’s phospholipids and glycolipids.  Several 
characteristics of medium chain fatty acids make them appealing as a natural treatment for 
animal health, including their generally recognized as safe (GRAS) status conferred by FDA, and 
toxicity studies have shown them to be non-toxic in animal diets even at high levels (Code of 
Federal Regulation 21CFR 184.1025, 1981; Traul et al., 2000).  Medium chain fatty acids have 
been investigated for their potential to eliminate Campylobacter based upon their reported high 
broad spectrum antibacterial activity (Van Immerseel et al., 2004; Nair et al., 2005).  
Experiments by Chaveerach and coworkers. (2002, 2004) have confirmed the antimicrobial 
activity of organic acids when used as a component of feed and in the water system and a 
subsequent in vivo trial demonstrated that administration of organic acids through the drinking 
water kept the water free of Campylobacter and the birds had no adverse clinical or histological 
effects.  In vivo trials utilizing broiler chicks demonstrated a 3-4 log reduction in cecal 
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Campylobacter colonization when a single medium chain organic acid, caprylic acid, was 
administrated as a prophylactic or theraputic treatment in feed (Solis de los Santos et al., 2008a; 
Solis de los Santos et al., 2008b; Solis de los Santos et al., 2009).  The feeding of combinations 
of medium chain fatty acids has been shown to have a protective effect against colonization with 
Campylobacter by causing an increase in the required infective dose and demonstrating reduced 
levels of fecal shedding (van Gerwe et al., 2010; Molatova et al., 2011).  To date no studies have 
shown the complete failure of Campylobacter to colonize the ceca in response to medium chain 
fatty acids, but its efficacy in lowering shedding could give it potential as a therapeutic 
administered shortly before slaughter in order to reduce the bacterial load entering the slaughter 
facility (Solis de los Santos et al., 2010; Molatova et al., 2011). 
1.5.8 Plant Extracts 
The use of compounds extracted from plants, phytogenics, by producers of food animals 
is an area of resurgent interest due to growing consumer demand for removal of sub-theraputic 
administration of antibiotics in conventionally raised livestock and the increased demand for 
organic meat products (Sirsat et al., 2009; Organic Trade Association, 2011).  In the United 
States and European Union there is growing consumer demand for food products produced in a 
more sustainable and natural manner and the inclusion of plant extracts into food animal 
production aligns well with the general populations idea that ‘natural’ compounds are better and 
safer (Greathead, 2003). 
The majority of research has focused upon supplementation of plant compounds to 
replace antibiotic growth promoters (AGP) and their safety and effect on the chicken growth 
characteristics and gut health (Windisch et al., 2008).  The use of phytogenics for the control of 
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disease is a natural progression from research into replacements for AGP due to the knowledge 
regarding the bacteriostatic and bactericidal properties of numerous plant extracts (Helander et 
al., 1998; Smith-Palmer et al., 1998; Dorman and Deans, 2000; Guo et al., 2003).  The greatest 
amount of research in the area of antimicrobial action of plant extracts has centered upon 
essential oils, however the majority of studies in which antimicrobial activity was assayed was 
not done so in live animals (Griggs and Jacob, 2005).  The use of plant extracts in a research 
setting can become quite complicated due to several parameters: (1) plants may produce 
numerous bioactive compounds and determining which one is the source of antimicrobial 
activity may be cost and labor intensive (2) the concentration of bioactive compounds in plants 
can have significant variability due to location, growth conditions, time of harvest and method of 
storage (Greathead, 2003; Viskelis et al., 2009; Applegate et al., 2010). 
1.6 Use of Cranberry Extract for Preharvest Control of Campylobacter in Poultry 
The North American Cranberry (Vaccinium macrocarpon) is considered a plant with 
many positive health attributes for humans.  These positive attributes originate from the 
phytochemicals produced as secondary metabolites which serve to protect plants from harmful 
environmental stressors including UV light, free radicals, plant bacterial pathogens and 
herbivorous predators (Dixon et al., 2005; Stevenson and Hurst, 2007).  Research into the 
phytochemicals produced by cranberries has identified over 150 unique compounds (Pappas and 
Schaich, 2009).  Investigation into the bioactive compounds produced by cranberries that have 
potential beneficial effects on health, include phenolic acids and flavonoids including 
anthocyanins and proanthocyanidins (Neto, 2007; Pappas and Schaich, 2009; Côté et al., 2010; 
Lacombe et al., 2010; Côté et al., 2011a). 
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1.6.1 Bioactive Compounds 
Flavonoids produced by cranberries include flavonols, flavan-3-ols anthocyanins and 
proanthocyanidins (Sun et al., 2002; Pappas and Schaich, 2009; Côté et al., 2010).  Research into 
anthocyanins and proanthocyanidins of cranberry have determined that they exhibit strong in 
vitro antioxidant activity as they are capable of acting as hydrogen donors (Lin et al., 2005; 
Caillet et al., 2011).  The antioxidant activity of cranberry extracts, and of anthocyanins 
specifically, are affected by pH and exhibit greater antioxidant activity at lower than neutral pH 
(Wu et al., 2008; Caillet et al., 2011).  In general, the activity of bioactive secondary metabolites 
is dependent upon external environmental conditions including pH, temperature and composition 
of the solvent (Wu et al., 2008).  The health benefits of cranberry extract based upon antioxidant 
activity have been disputed due to research indicating that less than 5% of flavonoids are 
absorbed by the human body and absorbed flavonoids get rapidly metabolized and expelled from 
the body (Lotito and Frei, 2006; European Food Safety Authority, 2010d). 
1.6.2 Antimicrobial Activity 
Cranberry extract has been evaluated for antimicrobial activity and found to be inhibitory 
to wide range of Gram-positive and Gram-negative organisms (Puupponen-Pimiä et al., 2005a; 
Nohynek et al., 2006; Chi-Hua Wu et al., 2008; Lacombe et al., 2010; Côté et al., 2011a; Caillet 
et al., 2012).  Research trials which screened different cultivars of cranberry for antimicrobial 
activity have indicated that overall antimicrobial efficacy can depend upon many parameters 
including; specific cultivar, environmental conditions during growth, methods of storing raw 
material and which method is utilized to isolate the bioactive compounds (Viskelis et al., 2009).  
Fractionation of cranberry extract and analysis of the antimicrobial activity of each fraction has 
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demonstrated that flavonoids, which include anthocyanins and proanthocyanidins, and phenolic 
acids are responsible for up to 50% of the in vitro antimicrobial activity (Marwan and Nagel, 
1986).  Anthocyanins from cranberry extract have been investigated for their potential 
antimicrobial activity against the food borne pathogen E.coli O157:H7 and results indicate that 
there is significant bactericidal activity at the native pH of 2 (Lacombe et al., 2010).  However 
the use of anthocyaninis for control of bacterial pathogens can be complicated by their sensitivity 
to pH, oxygen levels and temperature (Lacombe et al., 2010).   
Cranberries contain a large amount of phenolic acid compounds, which are considered as 
one of the sources of the health promoting qualities of fruits and vegetables (Sun et al., 2002).  It 
has been suggested that the phenolic content of cranberry extract is responsible for the greatest 
amount of demonstrated antimicrobial activity (Wu et al., 2008).  Prior research has indicated 
that phenolics from berries were bactericidal to select human pathogens, including Salmonella 
spp., Escherichia coli, and Staphylococcus spp. (Puupponen-Pimiä et al., 2001; Nohynek et al., 
2006; Lacombe et al., 2010).  In an assay screening for potential antibacterial activity by various 
berry phenolic extracts, Nohynek and coworkers (2006) found that cranberry phenolic 
compounds had inhibitory activity against B. cereus, C. perfringens, S. epidermidis and Candida 
albicans but found no inhibition against C. jejuni, H. pylori and S. aureus. 
1.6.3 Mechanism of Action 
The mechanisms of antimicrobial action due to cranberry extract are not well understood and 
more investigation is required in this area.  However, the current research has indicated some 
potential mechanisms including inhibiting the uptake of necessary substrates, destabilization of 
bacterial membranes, and retarding bacterial growth by interruption of metabolism (Vattem et 
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al., 2004; Puupponen-Pimiä et al., 2005c; Nohynek et al., 2006).  Another potential mechanism 
of action for the antimicrobial activity of cranberry extract includes the ability of flavonoids, 
including proanthocyanidins and phenolic acids, to sequester free iron and thus prevent its 
availability for pathogenic bacteria (Dixon et al., 2005; Guo et al., 2007).  Bactericidal and 
bacteriostatic characteristics of cranberry have been attritubuted to the ability of some 
components of cranberry to prevent the adherence of bacteria to epithelial cells, which prevents 
colonization (Sobota, 1984; Zafriri et al., 1989; Howell et al., 1998).  Research into the 
prevention of urinary tract infections and the connection between consumption of cranberry 
products has led researchers to focus in on proanthocyanidins specifically, and results have 
indicated that they block the specific P fimbriae of Escherichia coli from attachment to 
uroepithelial cells (Howell et al., 1998; Foo et al., 2000; Howell et al., 2005).  The anti-
adherence properties of cranberry extract have also been investigated in regards to gastritis 
caused by H. pylori and dental caries caused by adherence of Gram-negative anaerobes to the 
gingival surface (Burger et al., 2000, 2002; Weiss et al., 2002).  The inhibition of H. pylori to 
attach to gastric epithelial cells was originally reported to be due to a high molecular weight 
component of cranberry and further work has suggested proanthocyanidins are responsible for 
this activity (Burger et al., 2000; Burger et al., 2002). 
1.6.4 Factors Influencing Bioactive Compounds of Cranberry 
As noted, the phytochemicals of cranberries can be influenced by many environmental 
factors both pre-processing and during juice extraction (Wu et al., 2008; Viskelis et al., 2009).  It 
is during the multiple steps of juice extraction, including freezing, crushing heating and 
evaporation that the bioactivity of cranberries compounds can be significantly affected (Côté et 
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al., 2011b).  Work by Caillet and coworkers (2011) demonstrated that the solvent utilized in the 
extraction process affected the antioxidant activity of cranberry phenolic compounds, whereby 
aqueous solvents increased antioxidant properties when compared to extraction using organic 
solvents.  The antimicrobial properties of cranberry juice and the resultant mash left over from 
processing are also influenced by juice extraction processes due in great part to flavonoids 
(anthocyanidins and phenolics) being readily oxidized and subsequently degraded (Côté et al., 
2011b).  Côte and coworkers (2011b) analyzed samples from each step of the juice making 
process for antimicrobial activity and concluded that in general the juicing process lowered the 
antibacterial potential of extracted flavonoids. 
Cranberry extracts have been studied within the poultry industry as a potential 
replacement to antibiotic growth promoters and found to have no adverse effect on the 
performance characteristics of broilers (Leusink et al., 2010).  The anti-adhesive properties of 
cranberry extract against E.coli and H.pylori make it a candidate for evaluation of these 
characteristics against Campylobacter jejuni colonization in poultry.  The objective of our study 
was to evaluate the efficacy of two cranberry extracts, differing in proanthocyanidin 
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ABSTRACT 
Campylobacter spp. has been identified as one of the leading causative agents of food borne 
diarrheal illness.  Epidemiological evidence has shown that poultry is the main source for human 
infection.  Poultry are asymptomatic carriers of Campylobacter within their gastrointestinal tract, 




 cfu/g cecal content.  Surveys of domestic poultry 
flocks have estimated that approximately 90% of flocks are positive for Campylobacter 
colonization.  Risk assessment studies have determined that by reducing levels of Campylobacter 
colonization within the gastrointestinal tract, incidences of human infection will be significantly 
reduced.  Currently there are no consistently effective treatments to eliminate Campylobacter 
from poultry flocks.  The use of natural plant extracts to control food borne pathogens is an area 
of resurgent interest due to growing consumer demand for removal of sub-theraputic 
administration of antibiotics in conventionally raised livestock and the increased demand for 
organic meat products.  Extracts from American Cranberry (Vaccinium macrocarpon) contain 
proanthocyanidins which have demonstrated antimicrobial activity against other food borne 
pathogens including E. coli, Salmonella, and Listeria.  However, their ability to reduce 
Campylobacter in chickens has not been reported.  The objective of this study was to evaluate 
the ability of two different cranberry extracts, either containing a lower (1%, L-PAC) or high 
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concentration (30%, H-PAC) of proanthocyanidins, to inhibit the growth of Campylobacter, in 
vitro and in vivo.  In replicate in vitro trials, treatments with 0.1 or 0.5% had no effect, the 1% 
treatment of L-PAC or H-PAC produced variable reductions of between 1 – 5 logs, and the 2 or 
4% treatments produced at least a 5 log reduction in Campylobacter counts when compared to 
controls 8 or 24 hours after inoculation for both the L-PAC or H-PAC.  For the in vivo studies, 
70 chicks were randomly assigned to one of seven treatment groups (n=10 per treatment group).  
Treatment groups for each trial included a positive Campylobacter control (no cranberry extract) 
or 0.5%, 1%, or 2% of either H-PAC or L-PAC added to the feed.  The same dosages were used 
in two replicate trials.  For each trial, all birds were given feed supplemented with H-PAC or L-
PAC, except for positive Campylobacter controls, starting at day of placement and continuing 
through the entire 14 day trial.  At day 7 all birds were challenged with a mixture of three wild 
type Campylobacter jejuni strains by oral gavage (approximately 2.5 x10
5
 cfu/mL).  On day 14, 
birds were euthanized by CO2 and cecal contents were collected for enumeration of 
Campylobacter.  In both trials cecal Campylobacter counts were not reduced by administration 
of L-PAC or H-PAC in the feed.  Follow up experiments are needed to increase the potency of 
these cranberry extracts to reduce this important food borne pathogen in chickens. 
INTRODUCTION 
One of the leading bacterial causes of food borne illness worldwide is contamination of 
food products with Campylobacter spp. (World Health Organization, 2001; European Food 
Safety Authority, 2011a; Scallan et al., 2011).  Estimates of food borne illness attributed to 
Campylobacter, based on data collected from the Centers for Disease Control (CDC), put the rate 
at approximately 850,000 cases per year (Scallan et al., 2011).  The numbers of estimated illness, 
and the true incidence are most likely much higher due to the fact that most Campylobacter 
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caused illnesses are sporadic in nature, large outbreaks are infrequent and microbiological 
methods for detection are variable (European Food Safety Authority, 2010a).  In rare cases, 
infection with Campylobacter has been associated with late onset morbidity including Guillain-
Barré syndrome, reactive arthritis and irritable bowel syndrome (Pope et al., 2007; Smith and 
Bayles, 2007; Spiller, 2007; Jacobs et al., 2008). 
Exposure and subsequent infection with C. jejuni, by way of contaminated poultry 
products, is one of the predominant causes of food borne related illness in the United States 
(Altekruse et al., 1999; Rosenquist et al., 2003; Friedman et al., 2004).  Epidemiological studies 
have indicated that the most frequent routes for human infection with Campylobacter are eating 
improperly cooked chicken, handling chicken and exposure to animals including poultry 
(Friedman et al., 2004; Danis et al., 2009; Lindmark et al., 2009; Fajó-Pascual et al., 2010).  
Campylobacter is able to colonize the chicken as a commensal, after which they become 
asymptomatic carriers (Beery et al., 1988; Dhillon et al., 2006).  Campylobacter preferentially 





cfu/gram of cecal material (Beery et al., 1988; Meinersmann et al., 1991; Evans, 1992; Stern et 
al., 1995; Cawthraw et al., 1996; Achen et al., 1998).  The prevalence of Campylobacter spp. 
within poultry flocks in the United States is reported to be as high as 90% (Stern et al., 2001b).  
The Food Safety and Inspection Service has estimated the percent of chicken carcasses positive 
for Campylobacter in the processing plant to be approximately 46%, which can be attributed to 
the feathers, the skin and the gastrointestinal tract having a high Campylobacter load which 
cannot be completely eliminated during processing (Jacobs-Reitsma et al., 1995; Wagenaar et al., 
2008).  High levels of Campylobacter on and in the bird at the time of slaughter have a 
significant impact on carcass contamination; so a reduction of Campylobacter in poultry pre-
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harvest should lead to a reduction in human campylobacteriosis cases from contaminated poultry 
products (Rosenquist et al., 2003; Reich et al., 2008; European Food Safety Authority, 2011b). 
Multiple strategies have been tried to reduce Campylobacter colonization in poultry 
which include: (1) increased biosecurity to limit the birds exposure to potential environmental 
sources (Adkin et al., 2006; Wagenaar et al., 2008); (2) utilization of naturally produced 
molecules from bacteria that have antibacterial activity against Campylobacter such as 
bacteriocins and bacteriophage (Carrillo et al., 2005; Stern et al., 2005; Svetoch et al., 2005; 
Wagenaar et al., 2005); (3) and the use of methods to prevent colonization of the ceca including 
vaccination, probiotic treatments and administration of natural compounds (Newell and 
Wagenaar, 2000; Stern et al., 2001a; Zoete et al., 2007; Lin, 2009; Solis de los Santos, 2010; 
Hoang et al., 2011b; Molatova et al., 2011).  Unfortunately, most of these strategies have met 
with limited success and additional treatments need to be developed to reduce this food borne 
pathogen in poultry. 
Renewed interest has been placed on plant extracts for the control of pathogens in food 
animals due in part to restrictions by the Food and Drug Administration (FDA) on antibiotic 
usage in livestock production (Food and Drug Administration, 2/24/12).  This challenges food 
animal producers to find alternatives to antibiotics and still maintain animal health and welfare 
(Tillman et al., 2011).  Alternatives to antibiotics may come from phytogenics, or plant derived 
compounds, some of which have the benefit of being designated as generally recognized as safe 
(GRAS) by FDA.  Compounds with GRAS designation as deemed safe to be used in foods and 
require no lengthy approval process, which allows them to adopted for use quickly (Code of 
Federal Regulation 21CFR 184.1025, 1981). 
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Plant extracts from the American Cranberry (Vaccinium macrocarpon) are GRAS and 
have many bioactive compounds, some of which demonstrate antimicrobial activity (Hong and 
Wrolstad, 1986; Marwan and Nagel, 1986; Puupponen-Pimiä et al., 2005b; Wu et al., 2008; Côté 
et al., 2010; Côté et al., 2011a).  The bioactive compounds of cranberries are linked to secondary 
metabolites called flavonoids, which include anthocyanins, proanthocyanidins and phenolic acids 
(Marwan and Nagel, 1986; Pappas and Schaich, 2009; Côté et al., 2010).  Research on 
flavonoids has found activity including: potent antioxidant action (Lin et al., 2005; Caillet et al., 
2011); iron chelation (Dixon et al., 2005; Guo et al., 2007), and inhibitory activity against 
bacterial adhesion to epithelial cells (Sobota, 1984; Zafriri et al., 1989; Howell et al., 1998).  
Cranberry extract has documented in vitro antibacterial activity to the food borne pathogens 
E.coli O157:H7, Salmonella Typhimuium, and Listeria monocytogenes (Wu et al., 2008; Caillet 
et al., 2012).  To our knowledge, cranberry extracts have not been evaluated for their ability to 
reduce Campylobacter in poultry. 
For this study two commercially available GRAS designated cranberry extracts were 
tested.  These extracts are standardized to contain a lower (1%) or higher concentration (30%) of 
proanthocyanidins by the manufacturer (L-PAC or H-PAC, respectively).  The aim of this 
research was to determine if cranberry extracts, L-PAC and H-PAC, are inhibitory to 
Campylobacter jejuni, in vitro and if efficacious, examine their potential for use in young 
chickens to prevent Campylobacter colonization. 
MATERIALS AND METHODS 
Cranberry Plant Extracts 
36 
 
Two extracts of the North American Cranberry (Vaccinium macrocarpon) were used for 
both the in vitro and in vivo trials; (1) cranberry concentrate powder standardized to contain 1% 
proanthocyanidins (L-PAC) and (2) dried cranberry extract powder standardized to contain 30% 
proanthocyanidins (H-PAC) obtained from Decas Botanical Synergies (Carver, MA). 
In vitro Antimicrobial Activity of Cranberry Extracts 
Assessment of in vitro antimicrobial activity was determined using a mixture of three 
wild type Campylobacter jejuni strains previously isolated and identified from poultry.  
Campylobacter was prepared as previously described (Farnell et al., 2005).  Briefly, a 10 µL 
loop of frozen glycerol stock of each C. jejuni strain was inoculated into 5 mL of Campylobacter 
Enrichment Broth (CEB) and incubated at 42
0
C for 48 hours under microaerophilic conditions.  
After 48 hours, 10 µL of each of the primary broth cultures were inoculated individually into 5 
mL of fresh CEB and incubated at 42
0
C for 24 hours under microaerophilic conditions.  
Following incubation, broth cultures were pooled in a 25 mL centrifuge tube.  A wet mount 
preparation was done to observe the mixed strain broth culture for viability and motility.  The 
broth culture was centrifuged for 10 minutes at 3,500 x g, and the supernatant was discarded.  
The remaining cell pellet was resuspended with an equal amount of Butterfield’s Phosphate 
Diluent (BPD).  For each assay, duplicate samples were tested which included eleven treatments, 
a positive control (no cranberry extract) and five concentrations (4%, 2%, 1%, 0.5% or 0.1%) of 
each cranberry extract.  Each assay was replicated two times.  To prepare the various 
concentrations of cranberry extract, 900 µL of fresh CEB was aliquoted into sterile test tubes and 
appropriate weights of L-PAC and H-PAC were added to the CEB and resuspended by 
vortexing.  A 100 µL aliquot of the three strain C. jejuni culture was inoculated into each 
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cranberry extract tube and a positive control tube (no cranberry extract).  Broth cultures were 
then incubated at 42
0
C under microaerophilic conditions and samples were taken at 8 hours or 24 
hours post-inoculation.  A 100 µL sample of each of the C. jejuni plus cranberry extracts was 
serially diluted (1:10) in Butterfield’s Phosphate Diluent (BPD) and direct plated onto Campy-
Line Agar (CLA) (Line, 2001) then incubated at 42
0
C under microaerophilic conditions for 48 
hours.  Presumptive Campylobacter colonies were directly enumerated and converted to cfu/mL 
of broth culture.  Bacterial colonies were confirmed by latex agglutination test (PANBIO Inc., 
Columbia, MD) and by API Campy (Biomeriuex Durham, NC). 
Animal Studies 
Day of hatch broiler chicks were obtained from a commercial hatchery.  Birds were 
weighed individually, placed in floor pens and provided free access to feed and water during the 
entire duration of the trials.  For each trial, 70 chicks were randomly assigned to one of seven 
treatment groups (n=10 per treatment group).  Treatment groups for each trial included a positive 
Campylobacter control (no cranberry extract) or 0.5%, 1%, or 2% of either H-PAC or L-PAC 
added to the feed.  The same dosages were used for Trial 2.  For each trial, all birds were given 
feed supplemented with H-PAC and L-PAC, except for positive Campylobacter control, starting 
at day of placement and continuing through the entire 14 day trial.  At day 7 all birds were 
challenged with a mixture of three wild type Campylobacter jejuni strains by oral gavage.  Each 
bird received 0.25 mL of an approximately 10
6
 cfu/mL Campylobacter jejuni mixture.  On day 
14, birds were euthanized by CO2 and cecal contents were collected for enumeration of 
Campylobacter.  Feed consumption was determined by subtracting the amount of remaining feed 
at day 14 from the amounts at day 1. 
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Campylobacter Challenge Preparation 
The Campylobacter challenge was prepared as previously described by Farnell and 
coworkers (Farnell et al., 2005).  Briefly, glycerol stock of the wild type Campylobacter jejuni 
strains, originally isolated from poultry, were inoculated individually into 5 mL of CEB.  Broth 
tubes were incubated at 42
0
C for 48 hours under microaerophilic conditions.  For the second 
passage, 10 µL loops from each strain were inoculated into 5 mL fresh CEB and incubated for 24 
hours at 42
0
C under microaerophilic conditions.  Following incubation, broth strains were pooled 
in a 25 mL centrifuge tube.  A wet mount preparation was done to observe the mixed broth 
culture for viability and motility.  The broth culture was centrifuged for 10 minutes at 3,500 x g, 
and the supernatant was discarded.  The remaining cell pellet was resuspended with an equal 
amount of BPD.  For quantitation of challenge dose a 100 µL aliquot was removed and serially 
diluted.  Each dilution was plated onto CLA then incubated at 42
0
C for 48 hours under 
microaerophilic conditions.  After the 48 hour incubation Campylobacter colonies were 
enumerated to determine the challenge dose. 
Campylobacter Enumeration from Ceca 
Campylobacter counts in the ceca were determined as described previously in our 
laboratory by Cole and coworkers (Cole et al., 2006a).  On day 14 cecal contents were collected 
and serially diluted (1:10) with BPD and inoculated onto CLA plates.  The CLA plates were 
incubated for 48 hours at 42
0
C under microaerophilic conditions.  Presumptive Campylobacter 
colonies were directly enumerated and converted to cfu/mL of cecal contents.  Bacterial colonies 
were confirmed by latex agglutination test (PANBIO Inc., Columbia, MD) and by API Campy 




Data were analyzed using PROC GLM procedure of SAS (SAS Institute, 2002).  The 
Campylobacter jejuni counts from the ceca were logarithmically transformed (log cfu/mL) 
before analysis to achieve homogeneity of variance (Byrd et al., 2003).  Treatment means were 
partitioned by LSMEANS analysis (SAS Institute, 2002) and probability of P < 0.05 was 
required for statistical significance. 
RESULTS 
In Vitro Antibacterial Activity of Cranberry Extracts 
There was no consistent reduction (>1 log) in Campylobacter counts for the 0.1 or 0.5% 
treatments at 8 or 24 hours post-inoculation for either the L-PAC (Table 1) or H-PAC (Table 2) 
treatments when compared with the controls in either trial.  For the 1% treatment, there was at 
least a one log reduction in Campylobacter counts for both compounds at 8 or 24 hours post 
dosing for both trials.  For the 2 or 4% doses, there was a greater reduction in counts for both 
time points and trials when compared with control for the L-PAC treatment (Table 1).  For H-
PAC, the 2 or 4% doses eliminated detectable Campylobacter in both trials (Table 2).   
Cecal Campylobacter Counts, Body Weights and Feed Consumption 
Cecal Campylobacter counts in 14 day old broiler chicks were not reduced by 
administration of L-PAC or H-PAC in Trial 1 or Trial 2 when compared with the Campylobacter 
positive control (Table 3).  Body weights were not affected feeding any dose of L-PAC in either 
trial when compared with controls (Table 3).  Body weights were, however, reduced in Trial 1 at 
the highest concentration and for the 1% and 2% H-PAC treatments in Trial 2 when compared 
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with controls (Table 4).  Although feed consumption was only determined for each pen at the 
end of the trials, the only consistent change for both trials was an increase in feed consumption in 
the 0.5% H-PAC treated birds versus the controls 
DISCUSSION 
In this study, we evaluated the potential for various doses of two different cranberry 
extracts, L-PAC and H-PAC, to inhibit the growth of Campylobacter jejuni in broth culture and, 
if efficacious, to test these compounds for their ability to reduce or eliminate Campylobacter 
colonization in young broiler chickens.  The in vitro antimicrobial susceptibility assays 
demonstrated that L-PAC and H-PAC at the lowest concentrations had little effect on 
Campylobacter growth.  However the higher concentrations of L-PAC was able to reduce 
Campylobacter by greater than 5 logs at 8 hours and to undetectable levels 24 hours after 
treatment.  For the H-PAC treatment, at both 8 and 24 hours, Campylobacter was reduced to 
undetectable levels.  These results indicated an apparent dose response relationship between the 
increasing concentrations of cranberry extracts and increasing efficacy against Campylobacter in 
vitro.  Furthermore, it appears that H-PAC is more effective against Campylobacter than L-PAC 
in these in vitro trials.  H-PAC has a higher concentration of proanthocyanidins than L-PAC 
which may explain its increased antibacterial activity against Campylobacter.  Experiments with 
proanthocyanidins have shown them to have antioxidant and iron scavenging properties (Dixon 
et al., 2005; Lin et al., 2005; Guo et al., 2007; Caillet et al., 2011) and may play a role in the in 
vitro anti-Campylobacter activity observed in our trials.  Although these compounds were 




It is possible that the inability of these cranberry extracts to reduce Campylobacter in 
young birds is because it was absorbed prior to reaching the ceca in the lower intestine and did 
not reach the ceca in concentrations high enough to reduce Campylobacter counts.  Although 
increasing the dose in the feed may be an option, it appears, at least for the higher doses of H-
PAC, this extract adversely affected the birds as demonstrated by a reduction in body weights.   
It is also known that pH and temperature affect the antioxidant activity of cranberry 
extracts (Wu et al., 2008; Côté et al., 2011b), which may not be optimal in birds.  Transition 
through the digestive system of the bird would subject these extracts to drastic changes in pH and 
the elevated body temperature of the chicken may also be a contributing factor (Thornton, 1962).  
Another possible reason that these cranberry extracts were not efficacious in vivo may be due to 
the niche Campylobacter occupies in the intestine.  Even if cranberry extracts reached the ceca at 
high concentrations it is possible that penetration into the crypts within the ceca may not occur.  
Campylobacter is able to sequester itself deep within the mucous filled crypts of the ceca, due to 
its chemoattraction to mucin, where it remains protected (Beery et al., 1988; Hugdahl et al., 
1988; Mead, 2002; Cole et al., 2006a).  Previous research from our laboratory observed that even 
when antibiotic treatment eliminated Campylobacter within other sites along the gastrointestinal 
tract, the crypts remained colonized (Farnell et al., 2005).   
The ability of Campylobacter to remain protected within the mucous in the crypts may 
also prevent exposure to the anti-adhesive capabilities of cranberry extracts (Foo et al., 2000; 
Howell et al., 2005).  Cranberry proanthocyanidins are able to prevent actin filaments of host 
cells from rearrangement, which is a mechanism used by some pathogenic bacteria for host cell 
invasion (Burger et al., 2000; Burger et al., 2002; Harmidy et al., 2011).  In vitro studies to 
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assess host cell invasion by Campylobacter jejuni have determined that it utilizes adhesions and 
secreted proteins to alter the actin cytoskeleton leading to membrane ‘ruffling’ then invasion 
(Eucker and Konkel, 2012).  The significance of this mechanism is supported by in vivo studies 
demonstrating that modified strains are unable to produce adhesion proteins are not capable of 
colonizing chickens (Biswas et al., 2003; Flanagan et al., 2009).  Therefore, treatments which 
reduce the mucous crypt concentrations may expose Campylobacter to the anti-pathogenic 
properties of cranberry extracts.  Research with bismuth compounds has demonstrated reductions 
in mucous viscosity and partial efficacy against Campylobacter colonization of the ceca 
(Wagstaff et al., 1988; Farnell et al., 2006).  Follow up experiments are planned to evaluate if co-
administration of bismuth and cranberry extracts can further reduce cecal Campylobacter 
colonization.   
Cranberry extracts contain many flavinoid compounds including anthocyanins and 
proanthocyanidins (Sun et al., 2002; Pappas and Schaich, 2009; Côté et al., 2010).  Research into 
the addition of flavonoids to improve poultry nutrition have shown that gut microbiota plays an 
essential role in the bioavailability of flavonoids, which require deglycosylation in order to be 
absorbed in the gut (Iqbal and Zhu, 2009).  Iqbal and coworkers (2009) were able to isolate and 
identify three Lactobacillus strains from chicken cecal contents that significantly improved the 
bioavailability of flavonoids.  This presents the opportunity for further study of cranberry 
extracts plus Lactobacillus strains as a potential pre-harvest intervention for Campylobacter 
colonization of poultry. 
The two cranberry extracts tested in this study were able to inhibit Campylobacter in 
vitro but not when tested in young chickens.  Follow up experiments are needed to increase the 
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potency of cranberry proanthocyanidins, such as combining them with lactic acid bacteria strains 
or bismuth compounds, which may reduce this important food borne pathogen in chickens. 
Table 1.  The effect of different concentrations of cranberry extract L-PAC on in vitro growth of 
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Table 2.  The effect of different concentrations of cranberry extract H-PAC on in vitro growth of 
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Table 3.  The effect of different treatments of cranberry concentrate L-PAC and H-PAC on cecal 
Campylobacter counts (log cfu/mL of cecal contents) in 14 day old broiler chicks (Means±SEM) 
during Trials 1 and 2
1
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Means within columns with no common superscript differ significantly (P<0.05). 
1
Chicks were given feed supplement with H-PAC or L-PAC from day of hatch to the end of the 
14 day study.  At day 7 birds were challenged by oral gavage (0.25mL) with approximately 10
6
 
cfu/mL of three strains of Campylobacter jejuni in both trials.  All Campylobacter data were 
log10 transformed for statistical analysis.  
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Table 4.  The effect of different treatments of cranberry extracts L-PAC and H-PAC on body 
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